Meet Craig Messick, M.D.
Craig A. Messick, M.D., FACS, FASCRS
Department of Colon & Rectal Surgery, Division of Surgery
In the News
Present Title & Affiliation
Primary Appointment
Associate Professor, Department of Colon and Rectal Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Associate Professor, Department of Colon and Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX
Clinical Interests
HPV-related diseases (pre-invasive and squamous cell carcinoma) of the anus, with particular interest in HPV-related disease that develop in patients not designated as high-risk; patients with bowel dysfunction after chemoradiation treatment for rectal cancer or other pelvic-related malignancies; inherited colorectal cancer syndromes; enhanced surgical recovery following traditional and minimally invasive surgery; optimizing the patient experience.
Education & Training
Degree-Granting Education
| 2005 | University of Texas Health Science Center, Houston, Texas, US, Medicine, MD |
| 1999 | Texas Christian University, Fort Worth, Texas, US, Biology, BS |
Postgraduate Training
| 2012-2013 | Colon and Rectal Surgery Fellowship, Cleveland Clinic Foundation, Cleveland, Ohio |
| 2007-2009 | Research Fellowship, Cleveland Clinic Foundation, Cleveland, Ohio |
| 2006-2012 | General Surgery Residency, University Hospitals Case Medical Center, Cleveland, Ohio |
| 2005-2006 | General Surgery Internship, University Hospitals Case Medical Center, Cleveland, Ohio |
Licenses & Certifications
| 2023 | Mississippi State Board of Medical Licensure |
| 2023 | Georgia Composite Medical Board |
| 2023 | Oklahoma State Board of Medical Licensure |
| 2023 | Washington State Department of Health |
| 2023 | Tennessee Board of Medical Examiners |
| 2023 | Alabama Board of Medical Examiners |
| 2023 | Louisiana State Board of Medical Examiners |
| 2023 | Arizona Board of Medical Examiners |
| 2021 | Florida Board of Medicine |
| 2017 | Fellow of the American Society of Colon and Rectal Surgeons |
| 2016 | Fellow of the American College of Surgeons |
| 2014 | American Board of Colon and Rectal Surgery |
| 2013 | DPS |
| 2013 | Texas Medical License |
| 2013 | DEA |
| 2013 | American Board of Surgery |
| 2007 | State Medical Board of Ohio |
Experience & Service
Faculty Academic Appointments
Assistant Professor, Department of Colon and Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - 2020
Resident ICU Jr. Staff, Department of Departments of General Surgery and Anesthesiology, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, OH, 2008 - 2009
Staff, Flight Physician, Department of Metro LifeFlight, MetroHealth Hospital, Cleveland, OH, 2007 - 2008
Administrative Appointments/Responsibilities
Executive Member, Department of Colon and Rectal Surgery, Faculty Senate, Houston, Texas, 2023 - 2025
Representative, Department of Colon & Rectal Surgery, Faculty Senate, Houston, TX, 2021 - 2025
Co-Chair, Chief Medical Executive (CME) Task Force for Classified Staff, Houston, TX, 2021
Other Professional Positions
Speakers Bureau, UT MD Anderson Cancer Center, HOUSTON, TX, 2018 - Present
Consultantships, MD Anderson Cancer Center Physician Network, Houston, TX, 2016 - 2017
Extramural Institutional Committee Activities
Department Representaive, OR Advisory Committee, The University of Texas MD Anderson Cancer Center, 2025 - Present
Member, ASCRS Quality and Safety Committee, American Society of Colon and Rectal Surgeons, 2025 - Present
Faculty Senate Representative, Presidents Workforce Community Council, The University of Texas MD Anderson Cancer Center, 2025 - Present
Committee Member representing: All Houston Area Locations (HALS) and the Division of Surgery, Governance Committee for Online Transparency, The University of Texas MD Anderson Cancer Center, 2021 - Present
Representative, REACH Member, Department of Colon and Rectal Surgery, The University of Texas MD Anderson Cancer Center, 2021 - Present
Division of Surgery & HALs Representative, Online Transparency Governance Committee, Patient Experience, The University of Texas MD Anderson Cancer Center, 2021 - Present
Member, Value Analysis Team (VAT) Committee Member, Department of Colon and Rectal Surgery, The University of Texas MD Anderson Cancer Center, 2020 - Present
Member, Clinical Practice Guidelines Committee, The University of Texas MD Anderson Cancer Center, 2020 - Present
Department Alternative Representative, OR Advisory Committee, The University of Texas MD Anderson Cancer Center, 2020 - 2025
Member, EndHPV Control Advisory Panel, Surgical Oncology Representative, The University of Texas MD Anderson Cancer Center, 2018 - Present
SL Representative, MD Anderson Cancer Center Sugar Land Safety Committee Member, The University of Texas MD Anderson Cancer Center, 2018 - Present
SL Representative, Enhanced Recovery After Surgery (ERAS) Committee Member, The University of Texas MD Anderson Cancer Center, 2018 - Present
Department Representative, Value Analysis Team (VAT) Committee, Surgical Oncology, The University of Texas MD Anderson Cancer Center, 2017 - 2019
Member, High-Risk HPV Working Group, The University of Texas MD Anderson Cancer Center, 2015 - Present
Subject Matter Expert, EPIC Electronic Health Record Clinical Content Review Committee-Cancer Network Committee, The University of Texas MD Anderson Cancer Center, 2015 - 2017
Editorial Activities
Associate Editor, Colorectal Disease, 2018 - Present
Associate Faculty Member, Faculty 1000 Colorectal Clinical Trials Sub-Section, 2013 - Present
Honors & Awards
| 2025 - Present | National Top 10 Percentile for Patient Experience Related to CAHPS Scores,, CAHPS |
| 2024 - Present | National Top 1 Percentile for Patient Experience Related to CAHPS Scores,, CAHPS |
| 2022 | National Perfect Provider score for Patient Experience Related to CAHPS, CAHPS |
| 2021 - 2022 | National Top 1 Percentile for Patient Experience Related to CAHPS Scores,, CAHPS |
| 2018 - 2020 | National Top 1 Percentile for Patient Experience Related to CAHPS Scores, CAHPS |
| 2017 - 2018 | National Top 1 Percentile Patient Experience Scores, CG CAHPS |
| 2013 | Most Valuable Player Award, Cleveland Clinic Foundation |
| 2009 | Harry E. Bacon, MD Foundation Award, Best Basic Science Podium Presentation, American Society of Colorectal Surgeons (ASCRS) Annual Meeting |
| 2008 - 2009 | Sanford R. Weiss, MD, Scholar |
| 2007 - 2009 | Dudley P. Allen, MD, Scholar |
| 2005 | Deans List |
Professional Memberships
Selected Presentations & Talks
Regional Presentations
- 2026. Non-malignant anorectal disorders. Invited. PACE Education Lecture Series. Houston, TX, US.
National Presentations
- 2024. The Multi-Disciplinary Approach to Rectal Cancer. Invited. 2024 APP Oncology Summit - Austin. Austin, US.
- 2017. MESSICK / TO DO. Invited. SCS General Surgery Education Day, Michigan, US.
- 2015. Surgical Considerations for Colon and Rectal Cancer. Conference. UT MD Anderson Cancer Center. Houston, TX, US.
- 2015. Now That the Colon has been Removed, What's Next?. Invited. The American Society of Colorectal Surgeons Annual Meeting (ASCRS). Boston, MA, US.
- 2013. Risk Factors and Incidence of Clostridium Difficile Infection after Colorectal Surgery. Invited. 99th Annual Clinical Congress Meeting of the American College of Surgeons (ACS). Washington, DC, US.
- 2013. What are the Risk Factors that Predict Recurrent Clostridium Difficle Infections in Surgical Patients?. Invited. 99th Annual Clinical Congress Meeting of the American College of Surgeons (ACS). Washington, DC, US.
- 2013. Right Colectomy Protects Patients with Methylator Colon Cancers Against Metachronous Serrated Neoplasia. Invited. The American Society of Colorectal Surgeons (ASCRS) Annual Meeting. Phoenix, AZ, US.
- 2012. Tumors Confined to the Presacral Space: a Diverse Group Requiring Individualized Evaluation and Surgery. Invited. 54th Annual Surgical Society of the Alimentary Tract Meeting as part of Digestive Disease Week (DDW/SSAT). Orlando, FL, US.
- 2010. The Regulatory Role of Micro-RNA Let-7a During Colorectal Cancer Metastasis. Invited. The American Society of Colorectal Surgeons (ASCRS) Annual Meeting, Research Forum. Minneapolis, MN, US.
- 2010. MIR-145A: A Novel Regulator of Colorectal Cancer Metastasis. Invited. 5th Annual Academic Surgical Congress (ASC). San Antonio, TX, US.
- 2009. Colon and Rectal Cancer: A Translational Colorectal Cancer Lab Perspective. Invited. Cancer Biology Research Seminar, Cleveland Clinic. Cleveland, OH, US.
- 2009. The Truth About Advanced Stage Colorectal Cancer: What the Primary Lesions Don't Tell You. Invited. The American Society of Colorectal Surgeons (ASCRS) Annual Meeting. Hollywood, FL, US.
- 2009. Not All are Created Equal: Genetic and Molecular Heterogeneity of Colon Cancer Hepatic Metastases. Invited. 4th Annual Academic Surgical Congress (ASC). Fort Myers, FL, US.
- 2009. CEACAM-7: A Predictor of Rectal Cancer Recurrence. Invited. 4th Annual Academic Surgical Congress (ASC). Fort Myers, FL, US.
- 2008. Molecular and Genetic Changes in Colorectal Cancer Hepatic Metastases. Invited. 29h Annual Turnbull Symposium. Cleveland, OH, US.
- 2008. Sessile Serrated Polyps: Implications of New Definitions on Old Colonoscopic Findings. Invited. The American College of Surgeons (ACS) Annual Meeting, poster. San Francisco, CA, US.
- 2008. Colorectal Cancer Hepatic Metastases. Invited. Cancer Biology Research Seminar, Cleveland Clinic. Cleveland, OH, US.
- 2008. Loss of Microsatellite Stability is Key in Formation of Serrated Polyps and Cancers. Invited. Tripartite meeting of the American Society of Colon and Rectal Surgeons (ASCRS), Research Forum. San Diego, CA, US.
- 2008. Recurrence of Early Stage Rectal Cancer is Associated with Decreased Expression of CEACAM-7. Invited. American Association for Cancer Research (AACR), poster. San Diego, CA, US.
- 2008. What's in a Name? The Clinical Importance of Accurate Histological Classification of Serrated Colorectal Polyps. Invited. 3rd Annual Academic Surgical Congress (ASC). San Diego, CA, US.
- 2007. Early Experience with Intraoperative Radiotherapy in Patients with Resected Pancreatic Adenocarcinoma. Invited. 48th Annual Surgical Society of the Alimentary Tract as part of Digestive Disease Week (DDW/SSAT). Washington, DC, US.
International Presentations
- 2018. Late, Rarely Reported Skin Complication After The Use of Hyperthermic Intraperitoneal Chemotherapy in a Female Patient. Invited. 11th International Workshop on Peritoneal Surface Malignancy. Paris, FR.
- 2018. Reasons for Hospital Readmission Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Invited. 11th International Workshop on Peritoneal Surface Malignancy. Paris, FR.
- 2018. Stapled Versus Hand-Sewn Intestinal Anastomosis in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemptherapty (CRS/HIPEC). Invited. 11th International Workshop on Peritoneal Surface Malignancy. Paris, FR.
- 2018. Palliative Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) Provides Durable Disease and Ascities Control for Patients with Appendicial Adenocarcinoma with Extensive Peritoneal Metastasis. Invited. 11th International Workshop on Peritoneal Surface Malignancy. Paris, FR.
- 2018. Staged CRS/HIPEC: An Approach for Difficult Cases of Indolent Peritoneal Surface Malignancy. Invited. 11th International Workshop on Peritoneal Surface Malignancy. Paris, FR.
- 2017. Bridging Gaps in Oncology. Invited. Annual Congress of National Cancer Institute-Cairo University. Cairo, EG.
- 2009. Do Precursor Polyp Burdens Help Distinguish Lynch Versus Non-Lynch Microsatellite Unstable Colorectal Cancers?. Invited. The International Society of Gastrointestinal Hereditary Tumors (InSiGHT) Biannual Meeting. Dusseldorf, DE.
- 2009. Changes Causes of Death in Familial Adenomatous Polyposis: Signs of Progress but More Work to Do. Invited. The International Society of Gastrointestinal Hereditary Tumors (InSiGHT) Biannual Meeting. Dusseldorf, DE.
Formal Peers
- 2017. Benign Anorectal Disease. Visiting. Houston, TX, US.
- 2017. HPV-Related Disease and Benign Anal Disease. Visiting. Troy, MI, US.
- 2015. Panelist:"Now that the Colon has been Removed, What's Next?" Symposium for Hereditary Colorectal Cancer. Invited. Boston, MA, US.
- 2012. Panelist: Hereditary Colorectal Cancer, 5th Annual Cleveland Clinic Resident and Alumni Education Day. Invited. Cleveland, OH, US.
Grant & Contract Support
| Date: | 2025 - Present |
| Title: | Self-sampling to Optimize anal Lesion Outcomes (SOLO) |
| Funding Source: | Medical College of Wisconsin |
| Role: | PI |
| ID: | FP00023922 |
| Date: | 2021 - Present |
| Title: | Altering Intake, Managing Symptoms (AIMS) intervention for bowel dysfunction in rectal cancer survivors, SWOG Phase II RCT, R21-approved, Principle Investigator: Virginia Sun, PhD, RN, City of Hope Comprehensive Cancer Center, 1R21CA236057-01, $275,000.00 2/yrs, percent effort 2%, Protocol S1820 |
| Funding Source: | City of Hope Comprehensive Cancer Center |
| Role: | Co-I |
| ID: | 1R21CA236057-01 |
| Date: | 2018 |
| Title: | Tripartite Vision 20/20 Delphi Analysis: An International Consensus on Low Anterior Resection Syndrome |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| Date: | 2017 - 2018 |
| Title: | Annual anal sampling using DNA screening to identify men who have sex with men at risk for anal cancer |
| Funding Source: | NIH/NCI |
| Role: | Co-PI |
| ID: | FP00000903 |
| Date: | 2017 - 2021 |
| Title: | Incidence of Oropharyngeal, Anal and Penile Cancer in Men with Antibodies to Human Papillomavirus (HPV): Screening of Cancer Related to HPV in Men (HOUSTON), Protocol 2016-0109 |
| Funding Source: | MDACC Moonshots Grant |
| Role: | Co-I |
| Date: | 2015 - Present |
| Title: | Moonshots Grant involving HPV-associated disease and malignancies |
| Funding Source: | NIH/NCI |
| Role: | Collaborator |
Selected Publications
Peer-Reviewed Articles
- McDonald, J, Damron, EP, Das, P, Koay, EJ, Ludmir, EB, Minsky, B, Noticewala, SS, Smith, GL, Messick, C, Morris, VK, Holliday, EB. Can Patients With Recurrent or Primary Squamous Cell Carcinoma of the Anus in a Previously Irradiated Pelvis Receive Definitive Reirradiation?. Advances in Radiation Oncology 11(2), 2026. e-Pub 2026.
- Morris, VK, Xiao, W, Lin, K, Wong, CW, Wotman, MT, Holliday, EB, Huey, RW, Noticewala, SS, Ludmir, EB, Bent, AH, Ludford, K, Messick, C, Koay, EJ, Smith, GL, Konishi, T, Bednarski, BK, Chang, GJ, Koong, A, You, YN, Das, P, Gillison, M. Time Dependency for Human Papillomavirus Circulating Tumor DNA Detection after Chemoradiation as a Prognostic Biomarker for Localized Anal Cancer. Clinical Cancer Research 31(12):2399-2405, 2025. e-Pub 2025. PMID: 39873618.
- Bhutiani, N, Ochiai, K, Peacock, O, You, YN, Bednarski, BK, Messick, C, Skibber, JM, White, MG, Chang, GJ, Konishi, T, Uppal, A. ASO Visual Abstract. Annals of surgical oncology 32(6):4257-4258, 2025. e-Pub 2025. PMID: 40202570.
- Bhutiani N, Ochiai K, Peacock O, You YN, Bednarski BK, Messick C, Skibber JM, White MG, Chang GJ, Konishi T, Uppal A. Risk Factors for Regrowth After Nonoperative Management for Rectal Cancer. Ann Surg Oncol 32(5):3098-3105, 2025. e-Pub 2025. PMID: 39924589.
- Bertucci Zoccali M, Kimura CMS, Chapman BC, Cuming T, Fong CF, Jay N, Kaplan JA, Khan MJ, Messick CA, Simianu VV, Sugrue JJ, Barroso LF 2nd. Management of Anal Dysplasia: A Pragmatic Summary of the Current Evidence and Definition of Clinical Practices for Prevention, Diagnosis, and Treatment. Dis Colon Rectum 68(3):272-286, 2025. e-Pub 2025. PMID: 39641452.
- Agnes A, Nguyen ST, Konishi T, Peacock O, Bednarski BK, You YN, Messick CA, Tillman MM, Skibber JM, Chang GJ, Uppal A. Early Postoperative Prediction of Complications and Readmission After Colorectal Cancer Surgery Using an Artificial Neural Network. Dis Colon Rectum 67(10):1341-1352, 2024. e-Pub 2024. PMID: 38959458.
- Bhutiani N, Ochiai K, Awiwi MO, Rodriguez-Bigas MA, Uppal A, Peacock O, Messick C, White MG, Skibber JM, Bednarski BK, You YN, Chang GJ, Kaur H, Konishi T. Para-aortic Lymph Node Dissection for Colorectal Cancer: Predicting Pathologic Lymph Node Positivity and Optimizing Outcomes. Ann Surg Oncol 31(9):5962-5970, 2024. e-Pub 2024. PMID: 38836917.
- Sun V, Guthrie KA, Crane TE, Arnold KB, Colby S, Freylersythe SG, Braun-Inglis C, Topacio R, Messick CA, Carmichael JC, Muskovitz AA, Nashawaty M, Bajaj M, Cohen SA, Flaherty DC, O'Rourke MA, Jones L, Krouse RS, Thomson CA. SWOG S1820: A pilot randomized trial of the Altering Intake, Managing Bowel Symptoms Intervention in Survivors of Rectal Cancer. Cancer 130(13):2384-2394, 2024. e-Pub 2024. PMID: 38386696.
- Siby T, Shajimon A, Mullen D, Gillani S, Ong JR, Dinkins NE, Kruse B, Patel C, Messick C, Gourmelon N, Butler MR, Gottumukkala V. Leveraging Nursing Assessment for Early Identification of Post Operative Gastrointestinal Dysfunction (POGD) in Patients Undergoing Colorectal Surgery. Curr Oncol 31(7):3752-3757, 2024. e-Pub 2024. PMID: 39057148.
- Sun, V, Thomson, C, Crane, TE, Arnold, KB, Guthrie, KA, Freylersythe, SG, Braun-Inglis, C, Jones, L, Carmichael, JC, Messick, C, Flaherty, DC, Ambrale, S, Cohen, S, Krouse, R. Baseline characteristics and recruitment for SWOG S1820. Supportive Care in Cancer 32(6), 2024. e-Pub 2024. PMID: 38775966.
- Kapadia MR, Senatore PJ, Messick C, Hull TL, Shaffer VO, Morris AM, Dietz DW, Wexner SD, Wick EC. The value of national accreditation program for rectal cancer: A survey of accredited programs and programs seeking accreditation. Surgery 175(4):1007-1012, 2024. e-Pub 2024. PMID: 38267342.
- Damron EP, McDonald J, Rooney MK, Das P, Ludmir EB, Minsky BD, Messick C, Chang GJ, Morris VK, Holliday EB. Salvage Treatment of Recurrent or Persistent Anal Squamous Cell Carcinoma: The Role of Multi-modality Therapy. Clin Colorectal Cancer 23(1):85-94, 2024. e-Pub 2024. PMID: 38216367.
- Arzola A, Chang E, Rooney MK, Corrigan K, Das P, Ludmir EB, Koay EJ, Minsky BD, Smith GL, Messick C, Morris VK, Nebgen D, Crane CH, Holliday EB. Daily Vaginal Dilator Use During Radiation for Women With Squamous Cell Carcinoma of the Anus: Vaginal Wall Dosimetry and Patient-Reported Sexual Function. Pract Radiat Oncol 14(2):e105-e116, 2024. e-Pub 2024. PMID: 37898354.
- Fox DA, Bhamidipati D, Konishi T, Kaur H, You N, Raghav KPS, Ge PS, Messick C, Johnson B, Morris VK, Thomas JV, Shah P, Bednarski BK, Kopetz S, Chang GJ, Ludford K, Higbie VS, Overman MJ. Endoscopic and imaging outcomes of PD-1 therapy in localised dMMR colorectal cancer. Eur J Cancer 194:113356, 2023. e-Pub 2023. PMID: 37827065.
- Patel SV, Liberman SA, Burgess PL, Goldberg JE, Poylin VY, Messick CA, Davis BR, Feingold DL, Lightner AL, Paquette IM. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Reduction of Venous Thromboembolic Disease in Colorectal Surgery. Dis Colon Rectum 66(9):1162-1173, 2023. e-Pub 2023. PMID: 37318130.
- Bordeianou LG, Thorsen AJ, Keller DS, Hawkins AT, Messick C, Oliveira L, Feingold DL, Lightner AL, Paquette IM. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Fecal Incontinence. Dis Colon Rectum 66(5):647-661, 2023. e-Pub 2023. PMID: 40324433.
- Ludford K, Ho WJ, Thomas JV, Raghav KPS, Murphy MB, Fleming ND, Lee MS, Smaglo BG, You YN, Tillman MM, Kamiya-Matsuoka C, Thirumurthi S, Messick C, Johnson B, Vilar E, Dasari A, Shin S, Hernandez A, Yuan X, Yang H, Foo WC, Qiao W, Maru D, Kopetz S, Overman MJ. Neoadjuvant Pembrolizumab in Localized Microsatellite Instability High/Deficient Mismatch Repair Solid Tumors. J Clin Oncol 41(12):2181-2190, 2023. e-Pub 2023. PMID: 36623241.
- You YN, Moskowitz JB, Chang GJ, Mork ME, Rodriguez-Bigas MA, Bednarski BK, Messick CA, Tillman MM, Skibber JM, Nguyen ST, Kopetz S, Vilar E. Germline Cancer Risk Profiles of Patients With Young-Onset Colorectal Cancer: Findings From a Prospective Universal Germline Testing and Telegenetics Program. Dis Colon Rectum 66(4):531-542, 2023. e-Pub 2023. PMID: 35195555.
- Hernandez S, Das P, Holliday EB, Shen L, Lu W, Johnson B, Messick CA, Taniguchi CM, Skibber J, Ludmir EB, You YN, Smith GL, Bednarski B, Kostousov L, Koay EJ, Minsky BD, Tillman M, Portier S, Eng C, Koong AC, Chang GJ, Foo WC, Wang J, Soto LS, Morris VK. Differential Spatial Gene and Protein Expression Associated with Recurrence Following Chemoradiation for Localized Anal Squamous Cell Cancer. Cancers (Basel) 15(6), 2023. e-Pub 2023. PMID: 36980587.
- Elnaggar JH, Huynh VO, Lin D, Hillman RT, Abana CO, El Alam MB, Tomasic KC, Karpinets TV, Kouzy R, Phan JL, Wargo J, Holliday EB, Das P, Mezzari MP, Ajami NJ, Lynn EJ, Minsky BD, Morris VK, Milbourne A, Messick CA, Klopp AH, Futreal PA, Taniguchi CM, Schmeler KM, Colbert LE. HPV-related anal cancer is associated with changes in the anorectal microbiome during cancer development. Front Immunol 14:1051431, 2023. e-Pub 2023. PMID: 37063829.
- Batman S, Messick CA, Milbourne A, Guo M, Munsell MF, Fokom-Domgue J, Salcedo M, Deshmukh A, Dahlstrom KR, Ogburn M, Price A, Fleming ND, Taylor J, Shafer A, Cobb L, Sigel K, Sturgis EM, Chiao EY, Schmeler KM. A Cross-Sectional Study of the Prevalence of Anal Dysplasia among Women with High-Grade Cervical, Vaginal, and Vulvar Dysplasia or Cancer: The PANDA Study. Cancer Epidemiol Biomarkers Prev 31(12):2185-2191, 2022. e-Pub 2022. PMID: 36126275.
- Healy MA, Peacock O, Hu CY, Bednarski BK, Tillman MM, Messick C, Kaur H, Chang GJ. High Rate of Positive Circumferential Resection Margin in Colon Cancer: A National Appraisal and Call for Action. Ann Surg 276(6):1023-1028, 2022. e-Pub 2022. PMID: 33630474.
- De B, Corrigan KL, Rooney MK, Ludmir EB, Das P, Smith GL, Taniguchi CM, Minsky BD, Koay EJ, Koong A, Morris VK, Messick CA, You YN, Chang GJ, Westney OL, Nogueras Gonzalez GM, Holliday EB. Patient-Reported Bowel and Urinary Function in Long-Term Survivors of Squamous Cell Carcinoma of the Anus Treated With Definitive Intensity Modulated Radiation Therapy And Concurrent Chemotherapy. Int J Radiat Oncol Biol Phys 114(1):78-88, 2022. e-Pub 2022. PMID: 35589011.
- Corrigan KL, Rooney MK, De B, Ludmir ED, Das P, Smith GL, Taniguchi C, Minsky BD, Koay EJ, Koong A, Morris VK, Messick CA, Nogueras-Gonzalez G, Holliday EB. Patient-Reported Sexual Function in Long-Term Survivors of Anal Cancer Treated With Definitive Intensity Modulated Radiation Therapy and Concurrent Chemotherapy. Pract Radiat Oncol 12(5):e397-e405, 2022. e-Pub 2022. PMID: 35643295.
- DiPeri, TP, Newhook, TE, Day, RW, Chiang, YJ, Dewhurst, WL, Arvide, EM, Bruno, M, Scally, CP, Roland, CL, Katz, MH, Vauthey, JN, Chang, GJ, Badgwell, BD, Perrier, ND, Grubbs, EG, Lee, JE, Tzeng, CD, Bednarski, BK, Chen, IB, Comeaux, RJ, Cox, DM, Feig, BW, Fisher, SB, Fournier, KF, Ghebremichael, SJ, Gibson, H, Gourmelon, NC, Graham, PH, Hancher-Hodges, S, Hunt, KK, Ikoma, N, Ivey MPAS, SL, Keung, EZ, Ledet, CR, Limmer, AR, Mansfield, PF, Mayon, L, Messick, C, Popat, KU, Rajkot MPAS, NF, Rodriguez-Bigas, MA, Santos, DA, Skibber, JM, Speer, BB, Soliz, J, Tillman, MM, Torres, KE, Van Meter, A, Williams, UU, You, YN. A prospective feasibility study evaluating the 5x-multiplier to standardize discharge prescriptions in cancer surgery patients. Surgery Open Science 9:51-57, 2022. e-Pub 2022. PMID: 35663797.
- Adams AM, Vreeland TJ, Teshome M, Francescatti AB, Zheng L, Hunt KK, Katz MHG, Messick CA. American College of Surgeons Commission on Cancer Standard 5.7 for Total Mesorectal Excision for Mid-to-Low Rectal Cancer. J Am Coll Surg 234(6):1249-1253, 2022. e-Pub 2022. PMID: 35703824.
- Tchelebi LT, Eng C, Messick CA, Hong TS, Ludmir EB, Kachnic LA, Zaorsky NG. Current treatment and future directions in the management of anal cancer. CA Cancer J Clin 72(2):183-195, 2022. e-Pub 2022. PMID: 34847242.
- Taku N, Yi-Qian YN, Chang GJ, Ludmir EB, Raghav KPS, Rodriguez-Bigas MA, Holliday EB, Smith GL, Minsky BD, Overman MJ, Messick C, Boyce-Fappiano D, Koong AC, Skibber JM, Koay EJ, Dasari A, Taniguchi CM, Bednarski BK, Morris VK, Kopetz S, Das P. Benchmarking Outcomes for Definitive Treatment of Young-Onset, Locally Advanced Rectal Cancer. Clin Colorectal Cancer 21(1):e28-e37, 2022. e-Pub 2022. PMID: 34794903.
- Holliday EB, Morris VK, Johnson B, Eng C, Ludmir EB, Das P, Minsky BD, Taniguchi C, Smith GL, Koay EJ, Koong AC, Delclos ME, Skibber JM, Rodriguez-Bigas MA, You YN, Bednarski BK, Tillman MM, Chang GJ, Jennings K, Messick CA. Definitive Intensity-Modulated Chemoradiation for Anal Squamous Cell Carcinoma: Outcomes and Toxicity of 428 Patients Treated at a Single Institution. Oncologist 27(1):40-47, 2022. e-Pub 2022. PMID: 35305097.
- Swords DS, Bednarski BK, Messick CA, Tillman MM, Chang GJ, You YN. Quality and Location of the Surgical Episode Mediate a Large Proportion of Socioeconomic-Based Survival Disparities in Patients with Resected Stage I-III Colon Cancer. Ann Surg Oncol 29(1):706-716, 2022. e-Pub 2022. PMID: 34406541.
- De B, Ludmir EB, Messick CA, Cagley MC, Morris VK, Das P, Minsky BD, Taniguchi CM, Smith GL, Koay EJ, Koong AC, Mohan R, Holliday EB. Prognostic impact of lymphopenia and neutrophil-lymphocyte ratio for patients with anal squamous cell carcinoma. J Gastrointest Oncol 12(5):2412-2422, 2021. e-Pub 2021. PMID: 34790402.
- Dahlstrom KR, Anderson KS, Guo M, Kwon MC, Messick CA, Pettaway CA, Asomaning N, Hopper M, Price A, Xu L, Day AT, Gillenwater AM, Sturgis EM. Screening for HPV-related oropharyngeal, anal, and penile cancers in middle-aged men: Initial report from the HOUSTON clinical trial. Oral Oncol 120:105397, 2021. e-Pub 2021. PMID: 34182223.
- Hester R, Advani S, Rashid A, Holliday E, Messick C, Das P, You YN, Taniguchi C, Koay EJ, Bednarski B, Rodriguez-Bigas M, Skibber J, Wolff R, Chang GJ, Minsky BD, Foo WC, Rothschild N, Morris VK, Eng C. CEA as a blood-based biomarker in anal cancer. Oncotarget 12(11):1037-1045, 2021. e-Pub 2021. PMID: 34084278.
- Messick CA. Expert Commentary for Perianal Paget's Disease. Dis Colon Rectum 64(5):515-516, 2021. e-Pub 2021. PMID: 33661233.
- Sheffer CE, Al-Zalabani A, Aubrey A, Bader R, Beltraram-Hage M, Hawari F, Hutcez C, Bennett S, Carl E, Cranos C, Darville A, Greyber J, Kheson T, Hynes V, Kotsen C, Leone F, McConaha J, McCary H, Meade C, Messick CA, Morgan SK, Morris CW, Payne T, Retzlaff J, Santis W, Short E, Shumaker T, Steinberg M, Wendling A. The Emerging Global Tobacco Treatment Workforce: Characteristics of Tobacco Treatment Specialists Trained in Council-Accredited Training Programs from 2017 to 2019. Int J Environ Res Public Health 18(5), 2021. e-Pub 2021. PMID: 33801227.
- Sun R, Messick C, Wei LJ. Two-Stage Turnbull-Cutait Pull-Through Coloanal Anastomosis for Low Rectal Cancers. JAMA Surg 156(2):202-203, 2021. e-Pub 2021. PMID: 33175112.
- Keane C, Fearnhead NS, Bordeianou L, Christensen P, Espin Basany E, Laurberg S, Mellgren A, Messick CA, Orangio GR, Verjee A, Wing K, Bissett I, Collaborative Group LI. International consensus definition of low anterior resection syndrome. Colorectal Dis 22(3):331-341, 2020. e-Pub 2020. PMID: 32037685.
- Keane C, Fearnhead NS, Bordeianou LG, Christensen P, Espin Basany E, Laurberg S, Mellgren A, Messick C, Orangio GR, Verjee A, Wing K, Bissett IP. International consensus definition of low anterior resection syndrome. ANZ J Surg 90(3):300-307, 2020. e-Pub 2020. PMID: 32040983.
- Keane C, Fearnhead NS, Bordeianou LG, Christensen P, Basany EE, Laurberg S, Mellgren A, Messick C, Orangio GR, Verjee A, Wing K, Bissett I. International Consensus Definition of Low Anterior Resection Syndrome. Dis Colon Rectum 63(3):274-284, 2020. e-Pub 2020. PMID: 32032141.
- Messick CA. Treatment efficacy for human papillomavirus-related anal squamous cell dysplasia in an under-represented population: human immunodeficiency-negative, non-men having sex with men, and non-transplant population. Colorectal Dis 22(1):29-35, 2020. e-Pub 2020. PMID: 31344295.
- Sammour T, Malakorn S, Thampy R, Kaur H, Bednarski BK, Messick CA, Taggart M, Chang GJ, You YN. Selective central vascular ligation (D3 lymphadenectomy) in patients undergoing minimally invasive complete mesocolic excision for colon cancer: optimizing the risk-benefit equation. Colorectal Dis 22(1):53-61, 2020. e-Pub 2020. PMID: 31356721.
- Bednarski BK, Nickerson TP, You YN, Messick CA, Speer B, Gottumukkala V, Manandhar M, Weldon M, Dean EM, Qiao W, Wang X, Chang GJ. Randomized clinical trial of accelerated enhanced recovery after minimally invasive colorectal cancer surgery (RecoverMI trial). Br J Surg 106(10):1311-1318, 2019. e-Pub 2019. PMID: 31216065.
- Fokom Domgue J, Messick C, Milbourne A, Guo M, Salcedo MP, Dahlstrom KR, Chiao EY, Deshmukh AA, Sturgis EM, Schmeler KM. Prevalence of high-grade anal dysplasia among women with high-grade lower genital tract dysplasia or cancer: Results of a pilot study. Gynecol Oncol 153(2):266-270, 2019. e-Pub 2019. PMID: 30827725.
- Wu CF, Xu L, Fu S, Peng HL, Messick CA, Lairson DR. Health Care Costs of Anal Cancer in a Commercially Insured Population in the United States. J Manag Care Spec Pharm 24(11):1156-1164, 2018. e-Pub 2018. PMID: 30362917.
- Messick CA. The Authors Reply. Dis Colon Rectum 61(7):e352, 2018. e-Pub 2018. PMID: 29878958.
- Sammour T, Malakorn S, Bednarski BK, Kaur H, Shin US, Messick C, You YN, Chang GJ. Oncological Outcomes After Robotic Proctectomy for Rectal Cancer: Analysis of a Prospective Database. Ann Surg 267(3):521-526, 2018. e-Pub 2018. PMID: 27997470.
- Messick CA. Presacral (Retrorectal) Tumors: Optimizing the Management Strategy. Dis Colon Rectum 61(2):151-153, 2018. e-Pub 2018. PMID: 29337767.
- Tolopka TC, Messick CA. Successful Restoration of Fecal Continence Using Sacral Nerve Stimulation Following Chemoradiation and Transanal Excision of an Anal Melanoma With Partial Internal Anal Sphincter Resection: A Case Report. Neuromodulation 20(8):783-786, 2017. e-Pub 2017. PMID: 28150422.
- Ikoma N, You YN, Bednarski BK, Rodriguez-Bigas MA, Eng C, Das P, Kopetz S, Messick C, Skibber JM, Chang GJ. Impact of Recurrence and Salvage Surgery on Survival After Multidisciplinary Treatment of Rectal Cancer. J Clin Oncol 35(23):2631-2638, 2017. e-Pub 2017. PMID: 28657814.
- Messick CA, Hammel JP, Hull T. Risk Factors that Predict Recurrent Clostridium difficile Infections in Surgical Patients. Am Surg 83(6):653-659, 2017. e-Pub 2017. PMID: 28637570.
- Silva-Velazco J, Hull TL, Messick C, Church JM. Medical versus Surgical Patients with Clostridium difficile Infection: Is There Any Difference?. Am Surg 82(12):1155-1159, 2016. e-Pub 2016. PMID: 28234177.
- de Rosa N, Rodriguez-Bigas MA, Chang GJ, Veerapong J, Borras E, Krishnan S, Bednarski B, Messick CA, Skibber JM, Feig BW, Lynch PM, Vilar E, You YN. DNA Mismatch Repair Deficiency in Rectal Cancer: Benchmarking Its Impact on Prognosis, Neoadjuvant Response Prediction, and Clinical Cancer Genetics. J Clin Oncol 34(25):3039-46, 2016. e-Pub 2016. PMID: 27432916.
- Shin US, Nancy You Y, Nguyen AT, Bednarski BK, Messick CA, Maru DM, Dean EM, Nguyen ST, Hu CY, Chang GJ. Oncologic Outcomes of Extended Robotic Resection for Rectal Cancer. Ann Surg Oncol 23(7):2249-57, 2016. e-Pub 2016. PMID: 26856720.
- Messick CA, Kravochuck S, Church JM, Kalady MF. Metachronous serrated neoplasia is uncommon after right colectomy in patients with methylator colon cancers with a high degree of microsatellite instability. Dis Colon Rectum 57(1):39-46, 2014. e-Pub 2014. PMID: 24316944.
- Messick CA, Hull T, Rosselli G, Kiran RP. Lesions originating within the retrorectal space: a diverse group requiring individualized evaluation and surgery. J Gastrointest Surg 17(12):2143-52, 2013. e-Pub 2013. PMID: 24146338.
- Messick CA, Hull T, Hammel JP, Manilich E. What are the risk factors that predict recurrent clostridium difficile infections in surgical patients?. Journal of the American College of Surgeons 217(3):S24, 2013. e-Pub 2013.
- Messick CA, Rosselli G, Hull T. Presacral tumors:are they comparable in pediatric and adult patients?. Polish Journal of Surgery (Pol Przegl Chir) 85(5):253-61, 2013. e-Pub 2013.
- Messick CA, Londono JM, Hull T. Presacral tumors: how do they compare in pediatric and adult patients?. Pol Przegl Chir 85(5):253-61, 2013. e-Pub 2013. PMID: 23770525.
- Messick CA, Church J, Bennett A, Kalady MF. Serrated polyps: new classifications highlight clinical importance. Colorectal Dis 14(11):1328-37, 2012. e-Pub 2012. PMID: 22554089.
- Messick CA, Hull T, Rosselli G, Kiran, P. Tumors confined to the presacral space: a diverse group requiring individualized evaluation and surgery. Gastroenterology 142(1):S, 2012. e-Pub 2012.
- Messick CA, Sanchez J, Dejulius KL, Hammel J, Ishwaran H, Kalady MF. CEACAM-7: a predictive marker for rectal cancer recurrence. Surgery 147(5):713-9, 2010. e-Pub 2010. PMID: 20004437.
- Messick CA, Church JM, Liu X, Ting AH, Kalady MF. Stage III colorectal cancer: molecular disparity between primary cancers and lymph node metastases. Ann Surg Oncol 17(2):425-31, 2010. e-Pub 2010. PMID: 19885699.
- Messick CA, Church JM, Liu X, Kalady MF. The truth about advanced stage colorectal cancer: what the primary lesions don’t tell you. Annals of Surgical Oncology 17(2):425-31, 2010. e-Pub 2010.
- Messick CA, Church J, Casey G, Kalady MF. Identification of the methylator (serrated) colorectal cancer phenotype through precursor serrated polyps. Dis Colon Rectum 52(9):1535-41, 2009. e-Pub 2009. PMID: 19690479.
- Messick CA, Sanchez J, Dejulius KL, Church JM, Kalady MF. Genetic and molecular diversity of colon cancer hepatic metastases. Surgery 146(2):227-31, 2009. e-Pub 2009. PMID: 19628078.
- Messick CA, Sanchez JA, DeJulius KL, Church JM, Kalady MF. Not all are created equal:genetic and molecular heterogeneity of colon cancer hepatic metastases. Surgery 146(2):227-31, 2009. e-Pub 2009.
- Messick C, Hardacre JM, McGee MF, Siegel CT, Stellato TA, Sanabria JR, Kinsella TJ, Schulak JA. Early experience with intraoperative radiotherapy in patients with resected pancreatic adenocarcinoma. Am J Surg 195(3):308-11; discussion 312, 2008. e-Pub 2008. PMID: 18207129.
- Sanchez JA, DeJulius KL, Messick CA, Bronner MP, Casey G, Church JM, Kalady MF. Role of CpG island methylator phenotype (CIMP) in ulcerative colitis oncogenesis. Journal of Surgical Research 144(2):385-386, 2008. e-Pub 2008.
Invited Articles
- Messick, CA. Expert Commentary for Perianal Paget’s Disease. Dis Colon Rectum:515-516, 2021. e-Pub 2021. PMID: 33661233.
Review Articles
- Ochiai K, Bhutiani N, Ikeda A, Uppal A, White MG, Peacock O, Messick CA, Bednarski BK, You YN, Skibber JM, Chang GJ, Konishi T. Total Neoadjuvant Therapy for Rectal Cancer: Which Regimens to Use?. Cancers (Basel) 16(11), 2024. e-Pub 2024. PMID: 38893212.
- Bhutiani N, Peacock O, Uppal A, You YN, Bednarski BK, Skibber JM, Messick C, White MG, Chang GJ, Konishi T. The current multidisciplinary management of rectal cancer. Ann Gastroenterol Surg 8(3):394-400, 2024. e-Pub 2024. PMID: 38707228.
- Uppal, A, Bhutiani, N, Shen, JY, Alfaro, KD, Kell, R, Yousef, M, Yousef, A, Konishi, T, Holliday, EB, Morris, VK, Dasari, NV, Willis, JA, Newhook, TE, Bednarski, BK, You, YN, Peacock, O, Messick, C, Das, P, Chang, GJ, Kopetz, S. Association of pathologic nodal status with minimal residual disease after neoadjuvant treatment and resection of locally advanced rectal cancer. Journal of Clinical Oncology 42:205, 2024. e-Pub 2024.
- Eng C, Messick C, Glynne-Jones R. The Management and Prevention of Anal Squamous Cell Carcinoma. Am Soc Clin Oncol Educ Book 39:216-225, 2019. e-Pub 2019. PMID: 31099616.
- Santos DA, Alseidi A, Shannon VR, Messick C, Song G, Ledet CR, Lee H, Ngo-Huang A, Francis GJ, Asher A. Management of surgical challenges in actively treated cancer patients. Curr Probl Surg 54(12):612-654, 2017. e-Pub 2017. PMID: 29421024.
- Messick CA, Rodriguez-Bigas MA. Anal Dysplasia. Surg Oncol Clin N Am 26(1):33-43, 2017. e-Pub 2017. PMID: 27889035.
Editorials
- Messick, CA. Squamous Cell Carcinoma of the Anus: Who, How, Why?. The International Anal Neoplasia Society, 2019.
Abstracts
- de Rosa N, Rodriguez-Bigas MA, Chang GJ, Veerapong J, Borras E, Krishnan S, Bednarski B, Messick CA, Skibber JM, Feig BW, Lynch PM, Vilar E, You YN. DNA Mismatch Repair Deficiency in Rectal Cancer: Benchmarking Its Impact on Prognosis, Neoadjuvant Response Prediction, and Clinical Cancer Genetics. J Clin Oncol 34(25):3039-46, 2016. e-Pub 2016. PMID: 27432916.
- Messick CA, Hull T, Hammel JP, Manilich E. What are the risk factors that predict recurrent clostridium difficile infections in surgical patients?. Journal of the American College of Surgeons 217(3):S24. e-Pub 2016.
- Shin US, Nancy You Y, Nguyen AT, Bednarski BK, Messick CA, Maru DM, Dean EM, Nguyen ST, Hu CY, Chang GJ. Oncologic Outcomes of Extended Robotic Resection for Rectal Cancer. Ann Surg Oncol 23(7):2249-57, 2016. e-Pub 2016. PMID: 26856720.
- Messick CA, Manikich E, Sun C, Costedio M. Risk factors and incidence of clostridium difficile infection after colorectal surgery?. Journal of the American College of Surgeons 217(3):S26-S27, 2013. e-Pub 2013.
- DeJulius KL, Messick CA, Kalady MF. Matrix metalloproteinase 11 is a potential tumor biomarker for rectal cancer. Journal of Surgical Research, 2011. e-Pub 2011.
- Messick CA, Bennet A, Sanchez JA, Church JM, Kalady MF. What’s in a name? the clinical importance of accurate histological classification of serrated colorectal polyps. Journal of Surgical Research 144(2):298, 2008. e-Pub 2008.
- Clarke CN, Nguyen S, Cuddy A, Bednarski B, Chang GJ, Messick CA, Rodriguez-Bigas MA, Skibber JM, You YN. High Neutrophil-lymphocyte Ratio Confers Prognostic Significance in MSI-high Colorectal Cancer. ANN SURG ONCOL.
- Patel SH, Hu CY, Massarweh N, You N, Bednarski B, Messick CA, Rodriquez-Bigas MA, Skibber JM, Feig BW, Chang GJ. Improving Hospital Level Quality Assessment in Rectal Cancer Surgery. ANN SURG ONCOL.
- Conrad C, Weissinger D, Shiozaki H, Aloai T, Bednarski B, Messick CA, Chun YS, Vauthey N, Chang G, You N. Coordinated minimally-invasive multi-staged surgery for stage IV colorectal cancer. ANN SURG ONCOL.
Book Chapters
- Holliday, EB, Van Morris, VK, Messick, C. Anal and Colorectal Cancer, 200-214, 2024.
- Bordeianou, L, Messick, C. Low Anterior Resection Syndrome (LARS), 1047-1054, 2021.
- Morris, V, Messick CA, Holiday, E. Anal Cancer. In: The MD Anderson Manual of Medical Oncology, 2021.
- Messick CA, Butros, ME. Low Anterior Resection Syndrome: Future Directions in Treatment and Prevention. In: Seminars of Colon and Rectal Surgery, 2021.
- Eng, C, Messick CA, Glynne-Jones, R. The Management and Prevention of Anal Squamous Cell Carcinoma. In: Am Soc Clin Oncol Educ Book, 216-225, 2019.
- Sammour, T, Messick CA. Management of small bowel and pouch neoplasia in hereditary colorectal syndromes. In: Seminars in Colon and Rectal Surgery, 2018.
- Messick CA, Rodriguez-Bigas MA. Anal Dysplasia. In: Surg Oncol Clin N Am. 1, 33-43, 2017.
- Ahmed S, Messick CA, Eng C. Cancer of the Anal Canal. In: Textbook of Gastrointestinal Oncology, 2017.
- Messick CA. Anal Dysplasia. In: Surgical Oncology Clinics of North America, 33-43, 2017.
- Messick CA. Complications of Surgery on the Small and Large Intestine. In: Principles of Gynecologic Oncology Surgery, 2017.
- Messick CA, Santos, D. Complications of Surgery on the Small and Large Intestine. In: Principles of Gynecologic Oncology Surgery, 2017.
- Messick CA, Chang G. Laparoscopic Right Colectomy. In: Operative Techniques in Surgery. Wolters Kluver, 993-1000, 2014.
- Messick CA, Bordeianou, L. Functional Bowel Disorders in Colorectal Surgery. In: Diseases of the Colon and Rectum. 4th.
- Messick CA. Mesenteric Resection in Rectal Cancer. In: Medical and Surgical Diseases of the Mesentery.
Books (edited and written)
- Holliday, EB, Van Morris, VK, Messick, C. Anal and Colorectal Cancer, 2024.
- Bordeianou, L, Messick, C. Low Anterior Resection Syndrome (LARS), 2021.
Patient Reviews
CV information above last modified March 06, 2026